0 Yorumlar
0 hisse senetleri
4K Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Autoimmune Disease Market Share: Regional Growth and ForecastThe Autoimmune Disease Market Share report focused on the industry dynamics, including market growth elements. The report also identifies limitations and chances for high segments of market growth. Our world-renowned analyst team conducts a study that is a result of extensive primary and secondary research. The growth of the market is forecast with complex algorithms such as...0 Yorumlar 0 hisse senetleri 5K Views 0 önizleme
-
Autoimmune Disease Testing Market Share: Emerging Market Trends and ForecastsAutoimmune Disease Testing Market size was valued at USD 10.2 billion in 2022 and it is expected to be worth around USD 22.18 billion by 2030 growing at a remarkable GAGR of 10.2% over the forecast period 2023-2030. The autoimmune disease testing market share is a rapidly growing sector in the healthcare industry. With the increasing prevalence of autoimmune diseases worldwide, there is...0 Yorumlar 0 hisse senetleri 5K Views 0 önizleme
-
Autoimmune Disease Testing Market Size to Reach USD 22.18 billion by 2030 | SNS InsiderThe market size of the autoimmune disease testing industry reached a valuation of USD 10.2 billion in 2022. It is projected to witness substantial growth, estimated to be worth around USD 22.18 billion by 2030. This remarkable expansion is expected to occur at a compound annual growth rate (CAGR) of 10.2% during the forecast period from 2023 to 2030. Autoimmune Disease Testing Market Trends...0 Yorumlar 0 hisse senetleri 5K Views 0 önizleme
-
Intravenous Immunoglobulin Market Opportunity, Demand, recent trends, Major Driving Factors and Business Growth Strategies 2032The Intravenous Immunoglobulin Market continues to grow at a remarkable pace, with its valuation at USD 14.02 billion in 2024 and projected to reach USD 25.39 billion by 2032. This growth trajectory represents a compound annual growth rate (CAGR) of 7.72% between 2025 and 2032. The market’s expansion is closely tied to increasing cases of autoimmune and neurological disorders,...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
Sponsorluk